MarginsXMarginsX
Home › Markets › Health Care › TOVX

Theriva Biologics Inc. (TOVX)

TOVX trades on NYSE in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.1400
-2.85% on the day
Market cap
$6.4M
Nano cap
Revenue
No annual revenue filed since the period ending 2011-12-31
Net income
No annual revenue filed since the period ending 2011-12-31

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerTOVX on NYSE
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0000894158
SEC industry codePharmaceutical Preparations
Incorporated inNV

Financials

No annual revenue filed since the period ending 2011-12-31.

Warning signs

Cash runway
9.0 months
$8.5M cash at September 30, 2026
Share count, 1 year
+36.0%
2025-11-07 to 2026-11-10 · +6632.0% over 3 years
Going-concern doubt
Yes
10-Q filed November 12, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These factors raise substantial doubt about the Company's ability to continue as a going concern."
10-Q 2026-11-12
Cash and burn$8.5M cash; operating cash flow -$2.8M a quarter.Report 2026-09-30
Shares outstanding45,892,668 (2026-11-10); 33,739,643 a year earlier; 17,042,765 three years earlier. 3y figure adjusted for splits (1-for-25 overall).Cover page 2026-11-10
Reverse splits, 3 years1; latest 1-for-25 on 2024-08-26Source 2024-08-26
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 1 424B5 takedowns, 1 at the marketLatest 2025-12-03
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorBDO USA, P.C., Raleigh, North Carolina, United StatesPCAOB Form AP 2026-03-13
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$0-$1.5M-$2.9M$8.5M$1.7MNeeds four quarters10-Q 2026-11-12
Q2 2026
2026-06-30
$0-$3.2M-$3.1M$11.3M$1.7MNeeds four quarters10-Q 2026-08-11
Q1 2026
2026-03-31
$300K-$2.0M-$2.5M$14.4M$1.7MNeeds four quarters10-Q 2026-05-05
Q4 2025
2025-12-31
Not filed-$2.0M-$2.9M$13.1M$1.7MNeeds four quarters10-K 2026-03-12
Q3 2025
2025-09-30
Not filed-$4.4M-$4.3M$7.5M$1.8MNeeds four quarters10-Q 2026-11-12
Q2 2025
2025-06-30
Not filed-$13.1M-$4.7M$12.1M$56KNeeds four quarters10-Q 2026-11-12
Q1 2025
2025-03-31
Not filed-$4.3M-$4.8M$10.0M$51KNeeds four quarters10-Q 2026-11-12
Q4 2024
2024-12-31
Not filed-$4.4M-$4.7M$11.6M$92KNeeds four quarters10-K 2026-03-12

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52025-12-03
Latest annual report10-K2026-03-12
Latest quarterly / interim10-Q2026-11-12
Latest current report
FORM 8-K
8-K2026-11-12
Latest proxyDEF 14A2026-10-20

Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-17.6%
1 month-36.4%
3 months-39.1%
Year to date-33.3%
1 year-50.0%
From 52-week high-65.9%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
ENVBEnveric Biosciences Inc.$1.44-4.95%$6.4M
ADXNAddex Therapeutics Ltd$3.83-5.67%$6.5M
TCRTAlaunos Therapeutics Inc.$1.60-1.84%$6.7M
SNGXSoligenix Inc.$0.2882-10.22%$6.7M
FBLGFibroBiologics Inc.$0.9034-2.00%$6.1M
TPSTTempest Therapeutics Inc.$0.3418-10.50%$6.8M
XCURExicure Inc.$1.07-0.93%$7.0M
LTRNLantern Pharma Inc.$0.3890-10.18%$5.8M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier